this was gilead. this was an image out of gilead, and we are in 2018.ption of innocence. why is dr ford not also given that? she is not being accused of something. she is. she is being accused of lying. she is being accused of having an ulterior motive. through a proper investigation, and we can come to... crosstalk. process would be to have a very, very long stay. there is no harm done. you don't need to have this newjustice in place immediately. then it totally clears the air and it's a proper process. through before january. there's no need to rush this. marc, that is... of being a rapist on the supreme court. and he has been a finejustice. he was terrible. that is questionable. he was a conservative bigot. so many people have been watching and why this is so significant. the point is, obviously, it is a presidential nominee. that's how the system works. brett kavanaugh or somebody else. between conservative and liberal, through a number of decisions. majority for decades to come. before the court. and he would be the crucial vote on these issues. an

. >> gilead, it's been dragging for a while.many of the different biotechs, take a look at something like biogen, gilead today is having a good day i think it's taken a little time to go back to, i it was trading 7 2, now it's up to 77 any other person have an opinion on gilead. the space itself has done so well i pointed out some of these stocks that are left les than 5% in some cases way less than 5% >> if you look at gilead, the pipeline is one or two major drugs, so it's a question of when they come out with the next development of drug and the market hasn't given credit for it the same thing with celgene down 30%, because drug companies have so much cash flow. >> and there were ot as it relates to the cardiovascular therapeutics. >> good stuff, everybody please send your questions keep them coming go to cnbc.com/halimfte. coming up, final trades are next on the halftime report ♪ that's confident. but it's not kayak confident. kayak searches hundreds of travel and airline sites to find the best flights for us. so i'm more th

this was gilead. this was an image out of gilead, and we are in 2018. scary.octor ford not also given that? she is not being accused of something. she is. she is being accused of lying. she is being accused of having an all teary emotive. there is no way we are going to get to the bottom of it unless proper time is given to investigate the allegations, and i don't understand, if he does not wa nt don't understand, if he does not want this cloud hanging over him for the next 30 or 40 years he is on the court, that really, why not go through a proper investigation, and we can come to... crosstalk. they have been saying, you could have had, i interviewed a republican on friday, who said you could have had a long stay, not the one week we are looking at right now, the best thing to do for the due process would be to do for the due process would be to have a very, very long stay. there is no harm done. you don‘t need to have this newjustice in place immediately. then it totally clears the air and it is a proper process. and they still have time to get anotherjustic

give it up starting to feel better about things gilead this is a name i talked with tim earlier he alsothis name it's a great name here is why. there were opportunities here when the blood was in the streets not long ago look at the chart later. look at this management team it's a new management team and they have been aggressive. if you look in the last two years what have they done? made a hue acquisition kite that's something that's playing out and actually just this week part of what they are working with there on arthritis crewing o drug did put out good numbers. the stock jumped the other day great for the stock obviously. the solid fundamentals of the krp. trading at 11 pe pch also a 3% dividend yield also in the the last five years reduced share count by buying back stock by 15%. so they're doing frgt right. everything you'd want if you ar shareholder of this company. they're going out and they're being aggressive and buying. and what they're doing in terms of buying back stock and with the dividends. now the strong pipeline in the growth this is the thing i want to focus on mos

. >>> and gilead sciences says a drug to treat rheumatoid arthritis did reach its goals.ead are also investigating other uses for the drug includi including treating things like crohn's disease. >>> big business sounding off in a big way against the president's proposed tariffs kate rogers has more on this new group. >> a coalition of u.s. businesses are launching a new campaign today to counter president trump's tariffs. this ranges across from several industries from toys to tech and is being led by the national retail federation. it involves reaching out to lawmakers, buying ads and hosting town hall meetings in swing states the group is calling on congress to participate in events next week in illinois, pennsylvania and tennessee. they encourage congress to use its oversight role on trade policy issues to prevent further harm to u.s. workers, families and consumers. president trump has proposed tariffs on 2$200 billion worth o chinese imports which he says could soon be imposed and has threatened further action. groups argue that tariffs disrupt supply chains and lead

this was an image out of gilead and we are in 2018.ay you believe in the presumption of innocence but, what you're saying is you don't believe in it. why is she not given that trust? she's not being accused of anything. she is, she's being accused of lying. there's no way we're going to get to the bottom of that unless proper time is given to investigate the allegations. if he wants to clear his name and is and with this hanging over him, why not go through a proper investigation? i interviewed a republican on friday who said, he could have had a long stay, not just the one week we're looking at right now. the best thing to do for the due process was to have a very, very long stay, there's no harm done, you don't have to have this newjustice in place immediately, then it totally clears the air. they still have time to get another justice through before january, there is no need to rush this. we can't have someone accused of being a rapist in the supreme court. this is precisely what happened with clarence thomas and he has been a finej

he says it is hard to imagine gilead would make a move like this and competitors wouldn't respond.e war in hepatitis c drugs >> i'm wondering wloz revenues this question. most folks don't think this hurts gilead because it was already seeing the discounts on the drugs. who it could potentially affect are distributors as you mentioned, potentially pbms depending how much they benefit from the reebt getting paid on branded drugs. it says a lot about the drug supply chain this this might not affect the drug maker itself. >> all right meg tyrrell, thank you interesting story see if it is a trend. >> yeah. >> the pharma companies making their own jenn across. the fed expected to announce a rate hike. how many more hikes on the horizon? what's it mean for the economy. >> and coming up on "fast money," could the ico crackdown on the which for krip o. the head of relation for circle will tell us her view. top of the hour, "closing bell" back irsthand. like e-commerce spurring cardboard demand. the pursuit of allergy-free peanuts. n and mobile payment reaching new markets. this is strategic

it is a last place you would expect to find any sign of life gilead step aside and you will see a crossfactory and a lab. ♪ trays of produce or vertically steps to save space and each of them is given the right amount of light, water and nutrients at the optimal temperature and humidity. it is an incredible level of whycision which is she can grow them faster and with less water and pesticides. >> it tastes like candy apple. .hoa! this is sour! >> i >> i know. reporter: the majority of the facility is automated. the is collected by sensors and computer controls growing conditions for the crops. but the things the machines cannot do yet, katie and her take carean farmers of and even that is dictated by the software that runs this will operation. >> it lets me know what i need to do, what time i should do it, and that is how i get my day .one >> after a full day at the farm, katie likes to bring home jace ando her husband, her cat, burton. , basilmenu are two items for pesto pasta and mixed greens for a salad. >> i am terrified. everyone is judging. cheers, guys. >> cheers. glasses can >>

there's somebody working on a better mouse trap, so to speak. >> a lot of news in biotech between gilead> we know the semis are going down but there's good news bausch had a nice settlement so let's not lose sight of the fact that pharmaceuticals and hmos are doing quite well. >> how will you follow last night's show tonight >> all right one of the -- no, the hottest retailer in the country is five below. and this stock has added 100 points it's a great concept, a lot of people shorted it for no particular reason. it's a regional national story the old peter lynch method to find the best stock. it may be five below i have to remind david it's not like rei, it's not about clothing, it's about trinkets that teenagers love. >> you've been early on this one. "mad money," 6:00 p.m. when we come back, viacom's bob bakish what's next for the companiny the wake of moonves resigning from cbs dow is up 38 ♪ go big or go home, go big or go home ♪ >> good wednesday morning. welcome back to "squawk on the street." i'll carl quintinilla with sara eisen who is back at post nine at the new york stock ex

. >> caller: what do you think about gilead >> it's real low and cheap i wouldn't sell it here, but io not have reason to recommend the stock. robert in -- no, cyrus in new york cyrus. >> caller: jim, i wanted to get your take on encore capital. >> very, very hard hard business. you would have to do a huge amount of work to convince me to buy that one robert in massachusetts, robert. >> caller: hey, coach cramer, how are you doing? >> doing great thank you for calling me by my real name. what's up? >> caller: a little coaching on kfem, they are confusing me so much >> it's a foundry company and they don't make a lot of money that's the problem we would rather be in amd than foundry. keith in michigan. >> caller: boo-yah, and how are you this evening, professor? >> not bad thank you for asking how about you? >> caller: pretty good, except for two problems i'm so nervous i almost forgot how to say boo-yah and second of all, i am in a quandary regarding chevron >> the problem, chevron is a great american company, okay and it yields almost 4%. just hold on to it because it's a very well-r

. >>> and gilead sciences says a drug to treat rheumatoid arthritis did reach its goals. also investigating other uses for the drug including treating things like crohn's disease. that stock is up by 3.5%. >>> andrew ross sorkin is in washington to mark the tenth anniversary of the financial crisis commemorate, does that imply sort of not celebrate -- i don't think we're celebrating it >> marking it. >> we did come out of it some great things done back then by the guys you will talk about. >> we have come quite far. as joe mentioned, this week mrashgs t marks the tenth anniversary of the financial crisis a new cnbc documentary tells the story. i sat down with those who tried to save lehman brothers and its ceo, dick fuld, only to see the bank's last chance slip away >> they collected us all and said the barclays deal had fallen through and that he would she prepare for a lehman bankruptcy later in the day. >> they all wanted to know why, what happened? that was the place to start. right away you say where do we go next. >> we felt it alleviated us from having to take on t

i like gilead.el in pennsylvania joel >> caller: hi, jim thanks for taking my call. >> of course >> caller: hey, jim, my stock is simple tot >> it is a winner in this environment with oil going up and not stuck. i say yes. to alan in nevada. >> caller: happy monday to you, jimbo from sin city, loas wage, nevada hey, jim, i know you're high on retail segment of the ark and not high on the pot stock, no pun intended what about croc? how does it look >> i have not looked at crocs in years. that will be fun to look at. i used to like it a lot then a couple of shortfalls let me do some homework. to georgia in florida. georgia, florida >> caller: hey, jim. it's nice of you to take my call what do you think of silica holdings. >> no, no, i don't like the fracking-related stocks. i think that business is slowing so let's be very careful i need to go to rocco in pennsylvania rocco. >> caller: hey, jim, how are you doing? >> i'm doing well. how about you? >> caller: i'm doing well. curious about what your inp

this is before the same drug from gilead was rejected. scor se dropping more than 3%.g its first interview since rejecting a takeover offer. it's growth remains on track and it has no interest in becoming part of a larger insurance company. guy: the stock was born yesterday on the back of that news. let's talk about what is happening with the macro story. jumped to thedly highest since 2004, production and employment all picked up. companies are concerned with the potential complications from trade tariffs. there was a warning for -- from eml kashkari, that the crisis could threaten economic expansion. turkey could generate the spark. fedalked about the fact the may slightly push things too far. it could be the fed that breaks economic expansion. let's bring back marilyn watson. i want to talk about this chart, the ism versus emerging market. strong u.s. economy generates a strong global economy. the rest of the world catches the flu and vice versa. and i am is off wondering what it is. is emerging markets going to bearish on emerging markets? are we optimistic about w